Actionable news
0
All posts from Actionable news
Actionable news in XON: INTREXON CORP,

FDA Approves AquAdvantage® Salmon

MAYNARD, Mass., Nov. 19, 2015 /PRNewswire/ -- AquaBounty Technologies, Inc. (AIM: ABTU; OTC: AQBT), a biotechnology company focused on enhancing productivity in aquaculture, and a majority-owned subsidiary of Intrexon Corporation (XON), announces today that the U.S. Food and Drug Administration (FDA) has approved the Company's New Animal Drug Application for the production, sale, and consumption of its AquAdvantage® Salmon, an Atlantic salmon that has been genetically enhanced to reach market size in less time than conventional farmed Atlantic salmon.

Ronald L. Stotish, Ph.D., Chief Executive Officer of AquaBounty, commented, "AquAdvantage Salmon is a game-changer that brings healthy and nutritious food to consumers in an environmentally responsible manner without damaging the ocean and other marine habitats. Using land-based aquaculture systems, this rich source of protein and other nutrients can be farmed close to major consumer markets in a more sustainable manner."

The U.S. currently imports over 90% of all the seafood, and more specifically over 95% of the Atlantic salmon, it consumes. AquAdvantage Salmon will offer the opportunity for an economically viable domestic aquaculture industry while providing...


More